Concepedia

Publication | Open Access

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

15

Citations

27

References

2024

Year

Abstract

ClinicalTrials.gov Identifier: NCT03493048.

References

YearCitations

Page 1